| 1 | Concomitant Administration of Ozanimod and Serotonergic Antidepressants in Patients With Ulcerative Colitis or Relapsing Multiple Sclerosis | 3.0 | 3 | Citations (PDF) |
| 2 | Disease Clearance as a New Outcome in Ulcerative Colitis: a Systematic Review and Expert Consensus | 3.0 | 36 | Citations (PDF) |
| 3 | Myenteric Plexus Immune Cell Infiltrations and Neurotransmitter Expression in Crohn’s Disease and Ulcerative Colitis | 1.3 | 18 | Citations (PDF) |
| 4 | IL-20 controls resolution of experimental colitis by regulating epithelial IFN/STAT2 signalling | 21.2 | 25 | Citations (PDF) |
| 5 | The Safety, Tolerability, Pharmacokinetics, and Clinical Efficacy of the NLRX1 agonist NX-13 in Active Ulcerative Colitis: Results of a Phase 1b Study | 1.3 | 9 | Citations (PDF) |
| 6 | Spatial Single Cell Profiling Using Imaging Mass Cytometry: Inflammatory Versus Penetrating Crohn’s Disease | 1.3 | 2 | Citations (PDF) |
| 7 | Etrasimod for the Treatment of Ulcerative Colitis: Analysis of Infection Events from the ELEVATE UC Clinical Programme | 1.3 | 14 | Citations (PDF) |
| 8 | A global consensus on the definitions, diagnosis and management of fibrostenosing small bowel Crohn’s disease in clinical practice | 48.0 | 47 | Citations (PDF) |
| 9 | Hydrogel-Integrated Millifluidic Systems: Advancing the Fabrication of Mucus-Producing Human Intestinal Models | 4.8 | 6 | Citations (PDF) |
| 10 | In-hospital survival of critically ill COVID-19 patients treated with glucocorticoids: a multicenter real-world data study | 3.5 | 1 | Citations (PDF) |
| 11 | Diagnostic delay in inflammatory bowel diseases in a German population | 4.8 | 11 | Citations (PDF) |
| 12 | Effects of oral contrast agent on the viscoelastic properties of the terminal ileum investigated using magnetic resonance elastography | 1.5 | 1 | Citations (PDF) |
| 13 | Autologous regulatory T-cell transfer in refractory ulcerative colitis with concomitant primary sclerosing cholangitis | 21.2 | 79 | Citations (PDF) |
| 14 | Cardiac sarcoidosis presenting with complex conduction abnormalities as the first manifestation of widespread systemic sarcoidosis: a case report | 0.5 | 0 | Citations (PDF) |
| 15 | International Consensus on Definition of Mild-to-Moderate Ulcerative Colitis Disease Activity in Adult Patients | 2.2 | 13 | Citations (PDF) |
| 16 | iSTART-II: An Update on the i Support Therapy–Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative Colitis | 2.6 | 4 | Citations (PDF) |
| 17 | Bioactive photocrosslinkable resin solely based on refined decellularized small intestine submucosa for vat photopolymerization of in vitro tissue mimics | 3.4 | 7 | Citations (PDF) |
| 18 | Adipocyte autophagy limits gut inflammation by controlling oxylipin and <scp>IL‐10</scp> | 7.4 | 27 | Citations (PDF) |
| 19 | Transcranial direct current stimulation to reduce chronic pelvic pain in endometriosis: phase II randomized controlled clinical trial | 2.1 | 10 | Citations (PDF) |
| 20 | Deciphering Cellular Networks in Creeping Fat | 3.0 | 2 | Citations (PDF) |
| 21 | Uptake of Tropheryma whipplei by Intestinal Epithelia | 4.5 | 2 | Citations (PDF) |
| 22 | Proteolytic Activity of the Paracaspase MALT1 Is Involved in Epithelial Restitution and Mucosal Healing | 4.5 | 10 | Citations (PDF) |
| 23 | Differential Effects of Ontamalimab Versus Vedolizumab on Immune Cell Trafficking in Intestinal Inflammation and Inflammatory Bowel Disease | 1.3 | 4 | Citations (PDF) |
| 24 | Analysis of Circulating Food Antigen-Specific T-Cells in Celiac Disease and Inflammatory Bowel Disease | 4.5 | 6 | Citations (PDF) |
| 25 | Selection of cross-reactive T cells by commensal and food-derived yeasts drives cytotoxic TH1 cell responses in Crohn’s disease | 39.5 | 73 | Citations (PDF) |
| 26 | Feasibility of in vivo magnetic resonance elastography of mesenteric adipose tissue in Crohn’s disease | 1.5 | 6 | Citations (PDF) |
| 27 | A Core Outcome Set for Inflammatory Bowel Diseases: Development and Recommendations for Implementation in Clinical Practice Through an International Multi-stakeholder Consensus Process | 1.3 | 6 | Citations (PDF) |
| 28 | Feasibility of Intestinal<scp>MR</scp>Elastography in Inflammatory Bowel Disease | 3.5 | 20 | Citations (PDF) |
| 29 | Prospective, double-blind diagnostic multicentre study of confocal laser endomicroscopy for wheat sensitivity in patients with irritable bowel syndrome | 21.2 | 33 | Citations (PDF) |
| 30 | An Integrated Taxonomy for Monogenic Inflammatory Bowel Disease | 1.0 | 83 | Citations (PDF) |
| 31 | P494 A serum metabolite panel predicts Crohn’s disease relapse in patients discontinuing infliximab and continuing antimetabolite therapy: sub-analysis of the SPARE Trial | 1.3 | 0 | Citations (PDF) |
| 32 | P058 IL-36 signaling in Crohn’s disease – characterization of a patient with an IL36RA mutation | 1.3 | 0 | Citations (PDF) |
| 33 | Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients | 7.8 | 56 | Citations (PDF) |
| 34 | P096 Store-Operated Calcium Entry Controls Innate and Adaptive Immune Cell Function in Inflammatory Bowel Disease | 1.3 | 1 | Citations (PDF) |
| 35 | P402 Incidence and outcomes of herpes zoster in the ozanimod phase, 3 ulcerative colitis and relapsing multiple sclerosis clinical program | 1.3 | 4 | Citations (PDF) |
| 36 | Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases | 23.6 | 31 | Citations (PDF) |
| 37 | Ileal and colonic Crohn's disease: Does location makes a difference in therapy efficacy? | 4.2 | 23 | Citations (PDF) |
| 38 | IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL Consensus | 6.2 | 19 | Citations (PDF) |
| 39 | A Notch/STAT3-driven Blimp-1/c-Maf-dependent molecular switch induces IL-10 expression in human CD4+ T cells and is defective in Crohn´s disease patients | 7.1 | 27 | Citations (PDF) |
| 40 | Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004 | 0.3 | 73 | Citations (PDF) |
| 41 | TNF hampers intestinal tissue repair in colitis by restricting IL-22 bioavailability | 7.1 | 28 | Citations (PDF) |
| 42 | Presence of spondyloarthritis associated to higher disease activity and HLA-B27 positivity in patients with early Crohn's disease: Clinical and MRI results from a prospective inception cohort | 2.3 | 19 | Citations (PDF) |
| 43 | Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial | 1.3 | 12 | Citations (PDF) |
| 44 | Visualization of Inflammation in Experimental Colitis by Magnetic Resonance Imaging Using Very Small Superparamagnetic Iron Oxide Particles | 2.9 | 19 | Citations (PDF) |
| 45 | Frequency of Positive Familial Criteria in Patients with Adenocarcinoma of the Esophageal-Gastric Junction and Stomach: First Prospective Data in a Caucasian Cohort | 4.0 | 0 | Citations (PDF) |
| 46 | Level of Tumor Necrosis Factor Production by Stimulated Blood Mononuclear Cells Can Be Used to Predict Response of Patients With Inflammatory Bowel Diseases to Infliximab | 6.2 | 29 | Citations (PDF) |
| 47 | Severe Acute Respiratory Syndrome Coronavirus 2 Attachment Receptor Angiotensin-Converting Enzyme 2 Is Decreased in Crohn’s Disease and Regulated By Microbial and Inflammatory Signaling | 1.0 | 20 | Citations (PDF) |
| 48 | COVID-19—from mucosal immunology to IBD patients | 7.1 | 13 | Citations (PDF) |
| 49 | Location is important: differentiation between ileal and colonic Crohn’s disease | 48.0 | 121 | Citations (PDF) |
| 50 | Validation of the ‘Inflammatory Bowel Disease—Distribution, Chronicity, Activity [IBD-DCA] Score’ for Ulcerative Colitis and Crohn´s Disease | 1.3 | 32 | Citations (PDF) |
| 51 | Reprogramming Intestinal Epithelial Cell Polarity by Interleukin-22 | 2.6 | 9 | Citations (PDF) |
| 52 | Combination of Vedolizumab With Tacrolimus Is More Efficient Than Vedolizumab Alone in the Treatment of Experimental Colitis | 3.0 | 6 | Citations (PDF) |
| 53 | Recognition of food antigens by the mucosal and systemic immune system: Consequences for intestinal development and homeostasis | 2.9 | 7 | Citations (PDF) |
| 54 | Critical Illness and Systemic Inflammation Are Key Risk Factors of Severe Acute Kidney Injury in Patients With COVID-19 | 2.5 | 24 | Citations (PDF) |
| 55 | International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases | 5.0 | 75 | Citations (PDF) |
| 56 | P015 Differential expression in colitis-associated cancer compared to Crohn′s disease and ulcerative colitis | 1.3 | 0 | Citations (PDF) |
| 57 | P061 Immune cell infiltrations of myenteric plexus in IBD – characterization and implications | 1.3 | 0 | Citations (PDF) |
| 58 | Spatial heterogeneity of hepatic fibrosis in primary sclerosing cholangitis vs. viral hepatitis assessed by MR elastography | 3.5 | 16 | Citations (PDF) |
| 59 | P003 HDAC7 Controls Differentiation and Regeneration in the Intestinal Epithelium | 1.3 | 1 | Citations (PDF) |
| 60 | PuraStat in gastrointestinal bleeding: results of a prospective multicentre observational pilot study | 2.4 | 76 | Citations (PDF) |
| 61 | Innovative Diagnostic Endoscopy in Inflammatory Bowel Diseases: From High-Definition to Molecular Endoscopy | 2.6 | 13 | Citations (PDF) |
| 62 | Qualität in der Gastroenterologie – „Vorschläge der Kommission Qualität der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten zur ambulanten und stationären Qualitätssicherung“ | 0.3 | 2 | Citations (PDF) |
| 63 | Review article: distinctions between ileal and colonic Crohn's disease: from physiology to pathology | 3.9 | 23 | Citations (PDF) |
| 64 | Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8+ T cells | 7.1 | 79 | Citations (PDF) |
| 65 | Influence of fibrosis progression on the viscous properties of in vivo liver tissue elucidated by shear wave dispersion in multifrequency MR elastography | 3.4 | 28 | Citations (PDF) |
| 66 | Results from the German registry for refractory celiac disease | 0.3 | 5 | Citations (PDF) |
| 67 | International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey | 3.0 | 79 | Citations (PDF) |
| 68 | Extracellular Matrix Components as Diagnostic Tools in Inflammatory Bowel Disease | 2.9 | 8 | Citations (PDF) |
| 69 | A 39-Year-Old Man With Crohn's Disease and a Unclear Rash on His Left Cheek | 0.7 | 2 | Citations (PDF) |
| 70 | Safety and tolerability of a single infusion of autologous ex vivo expanded regulatory T cells in adults with ulcerative colitis (ER-TREG 01): protocol of a phase 1, open-label, fast-track dose-escalation clinical trial | 2.0 | 16 | Citations (PDF) |
| 71 | Reducing Pain in Experimental Models of Intestinal Inflammation Affects the Immune Response | 3.0 | 3 | Citations (PDF) |
| 72 | Janus Kinase inhibitors in the New Treatment Paradigms of Inflammatory Bowel Disease | 1.3 | 10 | Citations (PDF) |
| 73 | P393 Patient and physician perspectives on the management of inflammatory bowel disease: Role of steroids in the context of biologic therapy | 1.3 | 2 | Citations (PDF) |
| 74 | Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The Ten Do’s and Don’ts from the ECCO-COVID Taskforce | 1.3 | 91 | Citations (PDF) |
| 75 | Die Grenzen des G-DRG-Systems bei der Abbildung von Komplexität in der Universitätsmedizin | 0.3 | 5 | Citations (PDF) |
| 76 | Ulcerative colitis | 50.7 | 1,354 | Citations (PDF) |
| 77 | Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF? | 2.6 | 113 | Citations (PDF) |
| 78 | The impact of extra-musculoskeletal manifestations on disease activity, functional status, and treatment patterns in patients with axial spondyloarthritis: results from a nationwide population-based study | 3.7 | 30 | Citations (PDF) |
| 79 | Was wollen wir mit „Klug entscheiden“ erreichen? | 0.3 | 0 | Citations (PDF) |
| 80 | Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19) | 3.2 | 104 | Citations (PDF) |
| 81 | Pro-inflammatory TNF-α and IFN-γ Promote Tumor Growth and Metastasis via Induction of MACC1 | 5.1 | 82 | Citations (PDF) |
| 82 | Are Serum-Based Markers Going to Replace Faecal Neutrophil Markers in Ulcerative Colitis? | 1.3 | 1 | Citations (PDF) |
| 83 | Use of microbiological and patient data for choice of empirical antibiotic therapy in acute cholangitis | 2.4 | 37 | Citations (PDF) |
| 84 | Specific microbiota enhances intestinal IgA levels by inducing TGF‐β in T follicular helper cells of Peyer's patches in mice | 3.2 | 81 | Citations (PDF) |
| 85 | Molekulare Diagnostik der infektiösen Gastroenteritis | 0.4 | 2 | Citations (PDF) |
| 86 | Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19 | 17.1 | 1,245 | Citations (PDF) |
| 87 | Aktualisierte S3-Leitlinie Colitis ulcerosa – Living Guideline | 0.3 | 52 | Citations (PDF) |
| 88 | Aktualisierung der Colitis ulcerosa Leitlinie 2020 | 0.3 | 5 | Citations (PDF) |
| 89 | Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation | 1.0 | 120 | Citations (PDF) |
| 90 | P031 Impact of nutritional antigens in inflammatory bowel disease patients | 1.3 | 0 | Citations (PDF) |
| 91 | dPGS Regulates the Phenotype of Macrophages via Metabolic Switching | 4.0 | 4 | Citations (PDF) |
| 92 | Lipid droplet‐dependent fatty acid metabolism controls the immune suppressive phenotype of tumor‐associated macrophages | 7.2 | 292 | Citations (PDF) |
| 93 | HDAC inhibitors promote intestinal epithelial regeneration via autocrine TGFβ1 signalling in inflammation | 7.1 | 72 | Citations (PDF) |
| 94 | Improving treatment of patients with inflammatory bowel diseases: a controlled trial of a multifaceted intervention in two German cities | 1.9 | 2 | Citations (PDF) |
| 95 | Tumor-Surveillance bei chronisch entzündlichen Darmerkrankungen | 0.2 | 1 | Citations (PDF) |
| 96 | A pilot study of visceral fat and its association with adipokines, stool calprotectin and symptoms in patients with diverticulosis | 2.4 | 12 | Citations (PDF) |
| 97 | Perceived distress, personality characteristics, coping strategies and psychosocial impairments in a national German multicenter cohort of patients with Crohn’s disease and ulcerative colitis | 0.3 | 14 | Citations (PDF) |
| 98 | Transcranial direct current stimulation in inflammatory bowel disease patients modifies resting-state functional connectivity: A RCT | 1.5 | 29 | Citations (PDF) |
| 99 | P004 IL-22 affects barrier function and cell polarity by MAPK/PI3 kinase signal transduction | 1.3 | 1 | Citations (PDF) |
| 100 | P501 High TNF-production of CD14+ cells and short disease duration are independent predictive factors for response to Infliximab treatment | 1.3 | 0 | Citations (PDF) |
| 101 | P014 Disruption of epithelial barrier function by coeliac peripheral blood mononuclear cells | 1.3 | 0 | Citations (PDF) |
| 102 | P398 Leptin controls immune cell composition and activity in acquired generalised lipodystrophy with combined Crohn’s disease | 1.3 | 0 | Citations (PDF) |
| 103 | Microbial Colonization in Adulthood Shapes the Intestinal Macrophage Compartment | 1.3 | 10 | Citations (PDF) |
| 104 | Indirect comparison of vedolizumab and adalimumab for biologic-naive patients with ulcerative colitis | 1.8 | 4 | Citations (PDF) |
| 105 | Geschlechtsspezifische Unterschiede bei chronisch-entzündlichen Darmerkrankungen | 0.4 | 0 | Citations (PDF) |
| 106 | Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicansCell, 2019, 176, 1340-1355.e15 | 34.1 | 444 | Citations (PDF) |
| 107 | Celiac Disease Monocytes Induce a Barrier Defect in Intestinal Epithelial Cells | 4.5 | 20 | Citations (PDF) |
| 108 | Multi-parameter immune profiling of peripheral blood mononuclear cells by multiplexed single-cell mass cytometry in patients with early multiple sclerosis | 3.5 | 48 | Citations (PDF) |
| 109 | Metabolic Control of Epigenetics and Its Role in CD8+ T Cell Differentiation and Function | 5.1 | 50 | Citations (PDF) |
| 110 | Reduction of intra-abdominal pain through transcranial direct current stimulation | 1.3 | 9 | Citations (PDF) |
| 111 | Leptin induces TNFα-dependent inflammation in acquired generalized lipodystrophy and combined Crohn’s disease | 13.9 | 34 | Citations (PDF) |
| 112 | Low Sensitivity of Simtomax Point of Care Test in Detection of Celiac Disease in a Prospective Multicenter Study | 6.2 | 10 | Citations (PDF) |
| 113 | T-cell Composition in Ileal and Colonic Creeping Fat – Separating Ileal from Colonic Crohn’s Disease | 1.3 | 46 | Citations (PDF) |
| 114 | CapsoCam SV-1 Versus PillCam SB 3 in the Detection of Obscure Gastrointestinal Bleeding | 2.4 | 37 | Citations (PDF) |
| 115 | Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative Proctitis | 6.2 | 22 | Citations (PDF) |
| 116 | Aktualisierte S3-Leitlinie Colitis ulcerosa | 0.3 | 19 | Citations (PDF) |
| 117 | Intestinal development and homeostasis require activation and apoptosis of diet-reactive T cells | 10.7 | 27 | Citations (PDF) |
| 118 | Restless legs syndrome is a relevant comorbidity in patients with inflammatory bowel disease | 1.9 | 21 | Citations (PDF) |
| 119 | Validation of the ‘United Registries for Clinical Assessment and Research’ [UR-CARE], a European Online Registry for Clinical Care and Research in Inflammatory Bowel Disease | 1.3 | 17 | Citations (PDF) |
| 120 | Pulmonary Manifestation of Crohn's Disease Developed Under Treatment With Vedolizumab | 0.7 | 20 | Citations (PDF) |
| 121 | Aktuelle therapeutische Strategien beim Morbus Crohn | 0.0 | 0 | Citations (PDF) |
| 122 | Diagnostic and therapeutic single-operator cholangiopancreatoscopy with SpyGlassDS™: results of a multicenter retrospective cohort study | 2.4 | 67 | Citations (PDF) |
| 123 | Confocal endomicroscopy in diagnosis of intestinal chronic graft‐versus‐host disease | 2.2 | 2 | Citations (PDF) |
| 124 | Transitionsmedizin – strukturelle Lösungsansätze | 0.4 | 13 | Citations (PDF) |
| 125 | Adipokines and Their Role in Intestinal Inflammation | 5.1 | 82 | Citations (PDF) |
| 126 | Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease—A Multicenter Retrospective European Study | 3.0 | 64 | Citations (PDF) |
| 127 | The role of adipose tissue in inflammatory bowel diseases | 2.3 | 30 | Citations (PDF) |
| 128 | Chronisch entzündliche Darmerkrankungen: Leitsymptome und Diagnostik | 0.2 | 1 | Citations (PDF) |
| 129 | Immunohistochemical Study of Mitosis-regulatory Proteins in Gastroenteropancreatic Neuroendocrine Neoplasms | 1.2 | 7 | Citations (PDF) |
| 130 | Comparison of non-invasive assessment of liver fibrosis in patients with alpha1-antitrypsin deficiency using magnetic resonance elastography (MRE), acoustic radiation force impulse (ARFI) Quantification, and 2D-shear wave elastography (2D-SWE) | 2.4 | 30 | Citations (PDF) |
| 131 | Ustekinumab – eine Standortbestimmung | 0.3 | 1 | Citations (PDF) |
| 132 | Human microglia regional heterogeneity and phenotypes determined by multiplexed single-cell mass cytometry | 17.1 | 383 | Citations (PDF) |
| 133 | Guideline recommendations for treatment of patients with inflammatory bowel diseases are not implemented in clinical practice—results of a non-representative survey | 1.9 | 3 | Citations (PDF) |
| 134 | Accuracy of diagnostic tests and a new algorithm for diagnosing cytomegalovirus colitis in inflammatory bowel diseases: a diagnostic study | 1.9 | 18 | Citations (PDF) |
| 135 | Epithelial barrier dysfunction in lymphocytic colitis through cytokine-dependent internalization of claudin-5 and -8 | 4.5 | 38 | Citations (PDF) |
| 136 | Celiac Disease: Role of the Epithelial Barrier | 5.7 | 143 | Citations (PDF) |
| 137 | Ustekinumab als Therapeutikum bei Morbus Crohn | 0.4 | 1 | Citations (PDF) |
| 138 | Das Leitlinienprogramm der DGVS 2017 | 0.3 | 5 | Citations (PDF) |
| 139 | Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs | 12.4 | 171 | Citations (PDF) |
| 140 | Cytomegalovirus infection associated with inflammatory bowel disease | 23.6 | 33 | Citations (PDF) |
| 141 | Azathioprine allows glucocorticoid withdrawal – post hoc results of a prospective study in patients with inflammatory bowel diseases | 0.3 | 2 | Citations (PDF) |
| 142 | Patient Education in a 14-month Randomised Trial Fails to Improve Adherence in Ulcerative Colitis: Influence of Demographic and Clinical Parameters on Non-adherence | 1.3 | 26 | Citations (PDF) |
| 143 | New Treatment Options for Proctitis. A Prospective, Double Blind, Randomized Study of Budesonide Suppositories | 1.0 | 0 | Citations (PDF) |
| 144 | Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus—A Multicenter Retrospective Study | 3.0 | 33 | Citations (PDF) |
| 145 | Impact of Microbiota on Intestinal Immune Cell Composition and Intestinal Barrier Function | 1.0 | 3 | Citations (PDF) |
| 146 | Mend Your Fences | 5.7 | 567 | Citations (PDF) |
| 147 | Inflammatory cell infiltration and resolution of kidney inflammation is orchestrated by the cold-shock protein Y-box binding protein-1 | 5.0 | 57 | Citations (PDF) |
| 148 | Aktuelle therapeutische Strategien beim Morbus Crohn | 0.4 | 1 | Citations (PDF) |
| 149 | Oleate but not stearate induces the regulatory phenotype of myeloid suppressor cells | 3.5 | 42 | Citations (PDF) |
| 150 | HDAC as Versatile Regulators of the Intestinal Barrier Integrity and Epithelial Regeneration in Inflammatory Bowel Disease | 1.0 | 0 | Citations (PDF) |
| 151 | S2k Leitlinie Autoimmune Lebererkrankungen | 0.3 | 75 | Citations (PDF) |
| 152 | Role of visceral fat in colonic inflammation | 2.3 | 34 | Citations (PDF) |
| 153 | Wild immunology assessed by multidimensional mass cytometry | 2.5 | 34 | Citations (PDF) |
| 154 | P617 Extraintestinal autoimmune phenomena during treatment with vedolizumab | 1.3 | 8 | Citations (PDF) |
| 155 | P101 Interleukin-13 induces polarity defects in the intestinal epithelia | 1.3 | 0 | Citations (PDF) |
| 156 | P065 Effects of gut bacteria on the intestinal immune cell composition and barrier function | 1.3 | 0 | Citations (PDF) |
| 157 | P511 Baseline characteristics of ulcerative colitis patients in the vedolizumab PASS study: a cohort study assessing the safety and effectiveness of vedolizumab compared to other biologic agents (01) | 1.3 | 0 | Citations (PDF) |
| 158 | Anti-Adhesion Therapies in Inflammatory Bowel Disease—Molecular and Clinical Aspects | 5.1 | 67 | Citations (PDF) |
| 159 | The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models | 2.4 | 28 | Citations (PDF) |
| 160 | Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer | 1.7 | 24 | Citations (PDF) |
| 161 | Reduction of chronic abdominal pain in patients with inflammatory bowel disease through transcranial direct current stimulation | 4.4 | 51 | Citations (PDF) |
| 162 | ENaC Dysregulation Through Activation of MEK1/2 Contributes to Impaired Na+ Absorption in Lymphocytic Colitis | 3.0 | 23 | Citations (PDF) |
| 163 | MicroRNA-320a Strengthens Intestinal Barrier Function and Follows the Course of Experimental Colitis | 3.0 | 25 | Citations (PDF) |
| 164 | Adoptive transfer of M2 macrophages reduces neuropathic pain via opioid peptides | 9.2 | 121 | Citations (PDF) |
| 165 | Sa1860 Adipose Tissue T-Cells In Creeping Fat Might Impact Intestinal Inflammation | 1.0 | 0 | Citations (PDF) |
| 166 | Su1962 Lipid Metabolism Modulates Regulatory Phenotype of MDS | 1.0 | 0 | Citations (PDF) |
| 167 | Biosimilars in der Behandlung chronisch entzündlicher Darmerkrankungen | 0.3 | 1 | Citations (PDF) |
| 168 | EndoClot Polysaccharide Hemostatic System in Nonvariceal Gastrointestinal Bleeding | 2.4 | 54 | Citations (PDF) |
| 169 | Chronisch entzündliche Darmerkrankungen | 0.0 | 0 | Citations (PDF) |
| 170 | Kompetenznetz Darmerkrankungen | 1.4 | 2 | Citations (PDF) |
| 171 | Analysis of factors contributing to variation in the C57BL/6J fecal microbiota across German animal facilities | 2.9 | 221 | Citations (PDF) |
| 172 | Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases—A Prospective Study on Incidence and Severity | 1.3 | 97 | Citations (PDF) |
| 173 | Wirksamkeit, Verträglichkeit und Sicherheit von Cannabinoiden in der Gastroenterologie | 0.7 | 30 | Citations (PDF) |
| 174 | Faecal microbiota transplantation—A clinical view | 2.9 | 13 | Citations (PDF) |
| 175 | Results of the Fifth Scientific Workshop of the ECCO (II): Pathophysiology of Perianal Fistulizing Disease | 1.3 | 106 | Citations (PDF) |
| 176 | Myeloid-derived suppressor cells promote B-cell production of IgA in a TNFR2-dependent manner | 15.6 | 40 | Citations (PDF) |
| 177 | Impact of staged surgery on quality of life in refractory ulcerative colitis | 2.4 | 14 | Citations (PDF) |
| 178 | Impact of restless legs syndrome in patients with inflammatory bowel disease on sleep, fatigue, and quality of life | 1.9 | 16 | Citations (PDF) |
| 179 | Long-term response to gluten-free diet as evidence for non-celiac wheat sensitivity in one third of patients with diarrhea-dominant and mixed-type irritable bowel syndrome | 1.9 | 61 | Citations (PDF) |
| 180 | Preventive anti-CD2 treatment does not impair parasite control in a murine toxoplasmosis model | 5.6 | 1 | Citations (PDF) |
| 181 | Pathophysiologie der Zöliakie | 0.4 | 3 | Citations (PDF) |
| 182 | Refraktäre Zöliakie | 0.4 | 2 | Citations (PDF) |
| 183 | Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD | 3.0 | 250 | Citations (PDF) |
| 184 | Intestinal Microbiota and the Innate Immune System – A Crosstalk in Crohn’s Disease Pathogenesis | 5.1 | 42 | Citations (PDF) |
| 185 | Diversity of Intestinal Macrophages in Inflammatory Bowel Diseases | 5.1 | 161 | Citations (PDF) |
| 186 | Herpes Simplex Virus Sepsis in a Young Woman with Crohn’s Disease | 1.3 | 15 | Citations (PDF) |
| 187 | Targeting human CD2 by the monoclonal antibody CB.219 reduces intestinal inflammation in a humanized transfer colitis model | 2.8 | 12 | Citations (PDF) |
| 188 | IκBNS Regulates Murine Th17 Differentiation during Gut Inflammation and Infection | 0.6 | 29 | Citations (PDF) |
| 189 | Inflammatory bowel disease (IBD)-like disease in a case of a 33-year old man with glycogenosis 1b | 2.4 | 6 | Citations (PDF) |
| 190 | Seltenen Erkrankungen auf der Spur – das Register für Refraktäre Sprue | 0.3 | 2 | Citations (PDF) |
| 191 | Vedolizumab bei Colitis ulcerosa und Morbus Crohn: eine Standortbestimmung | 0.3 | 8 | Citations (PDF) |
| 192 | A case series in patients with enteropathy and granulomatous diseases | 2.4 | 4 | Citations (PDF) |
| 193 | Histone deacetylase 5 regulates the inflammatory response of macrophages | 4.1 | 70 | Citations (PDF) |
| 194 | FOXM1: A novel drug target in gastroenteropancreatic neuroendocrine tumors | 1.7 | 26 | Citations (PDF) |
| 195 | Postoperative therapy and maintenance of remission in Crohn’s disease | 0.1 | 0 | Citations (PDF) |
| 196 | α-Haemolysin of<i>Escherichia coli</i>in IBD: a potentiator of inflammatory activity in the colon | 21.2 | 64 | Citations (PDF) |
| 197 | Bacterial Translocation – Impact on the Adipocyte Compartment | 5.1 | 26 | Citations (PDF) |
| 198 | Aktualisierte S3-Leitlinie – „Diagnostik und Therapie des Morbus Crohn“ 2014 | 0.3 | 185 | Citations (PDF) |
| 199 | Chronisch entzündliche Darmerkrankungen: State of the Art | 0.2 | 0 | Citations (PDF) |
| 200 | Azathioprin in der Therapie des Morbus Crohn – eine Standortbestimmung vor dem Hintergrund aktueller Studien | 0.3 | 6 | Citations (PDF) |
| 201 | 455 Role of MDM2 as therapeutic target in gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) | 5.1 | 1 | Citations (PDF) |
| 202 | Role of fat and adipokines in intestinal inflammation | 2.3 | 53 | Citations (PDF) |
| 203 | Adipose-Tissue and Intestinal Inflammation – Visceral Obesity and Creeping Fat | 5.1 | 138 | Citations (PDF) |
| 204 | DOP001 Epithelial polarity is disrupted by interleukin-22 | 1.3 | 0 | Citations (PDF) |
| 205 | Intermittent Dyspnea and Cyanosis in a Newborn Caused by a Hairy Polyp | 1.0 | 5 | Citations (PDF) |
| 206 | Exploring & exploiting our ‘other self’ – Does the microbiota hold the key to the future therapy in Crohn's? | 3.0 | 13 | Citations (PDF) |
| 207 | Use of a Nutrition Support Protocol to Increase Enteral Nutrition Delivery in Critically Ill Patients | 1.2 | 24 | Citations (PDF) |
| 208 | Ätiopathogenese chronisch-entzündlicher Darmerkrankungen | 0.4 | 2 | Citations (PDF) |
| 209 | Therapy of complicated Crohn’s disease during pregnancy—an interdisciplinary challenge | 1.9 | 7 | Citations (PDF) |
| 210 | Histone Deacetylase Inhibitors Modulate Interleukin 6-dependent CD4+ T Cell Polarization in Vitro and in Vivo | 2.2 | 80 | Citations (PDF) |
| 211 | P115 The influence of maternal IBD on childbirth and further development of children | 1.3 | 0 | Citations (PDF) |
| 212 | P082 Divergent effects of gut bacteria altered in dysbiosis of inflammatory bowel disease on monocytes and macrophage polarisation | 1.3 | 0 | Citations (PDF) |
| 213 | P045 Macrophage subtypes disrupt the epithelium via deregulated tight junctions and induction of apoptosis | 1.3 | 0 | Citations (PDF) |
| 214 | DOP044 Patient education in a 14 month randomized trial fails to improve adherence in ulcerative colitis: Influence of demographic and clinical parameters on non-adherence | 1.3 | 7 | Citations (PDF) |
| 215 | Die Proktokolektomie bei Colitis ulcerosa | 0.6 | 4 | Citations (PDF) |
| 216 | Postoperative therapy and maintenance of remission in Crohn’s disease | 0.4 | 1 | Citations (PDF) |
| 217 | Adipokines from local fat cells shape the macrophage compartment of the creeping fat in Crohn's disease | 21.2 | 112 | Citations (PDF) |
| 218 | The Selective Phosphodiesterase 4 Inhibitor Roflumilast and Phosphodiesterase 3/4 Inhibitor Pumafentrine Reduce Clinical Score and TNF Expression in Experimental Colitis in Mice | 2.4 | 19 | Citations (PDF) |
| 219 | CCR7 deficiency causes diarrhea associated with altered ion transport in colonocytes in the absence of overt colitis | 7.1 | 8 | Citations (PDF) |
| 220 | Mesenteric fat—control site for bacterial translocation in colitis? | 7.1 | 80 | Citations (PDF) |
| 221 | IκBNS Protein Mediates Regulatory T Cell Development via Induction of the Foxp3 Transcription Factor | 23.3 | 89 | Citations (PDF) |
| 222 | Recombinant human beta 2-defensin fusion proteins as a tool to investigate defensin structure and function in small human intestinal tissue samples | 5.0 | 2 | Citations (PDF) |
| 223 | Chronisch-entzündliche Darmerkrankungen | 0.5 | 0 | Citations (PDF) |
| 224 | Interleukin-7 Links T Lymphocyte and Intestinal Epithelial Cell Homeostasis | 2.4 | 39 | Citations (PDF) |
| 225 | Regulation of Macrophage Phenotype in Crohn's Disease Hypertrophied Adipose Tissue | 1.0 | 0 | Citations (PDF) |
| 226 | Induction of M2 Macrophages via Inhibition of Histone Deacetylases | 1.0 | 0 | Citations (PDF) |
| 227 | Manifestation of Spontaneous and Early Autoimmune Gastritis in CCR7-Deficient Mice | 3.4 | 24 | Citations (PDF) |
| 228 | Inhibition of Histone Deacetylases in Inflammatory Bowel Diseases | 5.8 | 79 | Citations (PDF) |
| 229 | The Multifaceted Role of the Inflammasome in Inflammatory Bowel Diseases | 3.0 | 36 | Citations (PDF) |
| 230 | Characterization of Chromosomal Instability in Murine Colitis-Associated Colorectal Cancer | 2.4 | 14 | Citations (PDF) |
| 231 | Selective gelatinase blockage ameliorates acute DSS colitis | 5.6 | 24 | Citations (PDF) |
| 232 | Surveillance colonoscopy in patients with inflammatory bowel disease: comparison of random biopsy vs. targeted biopsy protocols | 1.9 | 94 | Citations (PDF) |
| 233 | Wahrnehmung der Schutzimpfung gegen die Neue Grippe H1N1 von Patienten mit Morbus Crohn oder Colitis ulcerosa | 0.2 | 3 | Citations (PDF) |
| 234 | Early post-operative measurement of cytokine plasma levels combined with pre-operative bilirubin levels identify high-risk patients after liver resection | 4.5 | 19 | Citations (PDF) |
| 235 | The distinct roles of MMP-2 and MMP-9 in acute DSS colitis | 5.6 | 37 | Citations (PDF) |
| 236 | What you eat is what you get: Novel<i>Campylobacter</i>models in the quadrangle relationship between nutrition, obesity, microbiota and susceptibility to infection | 5.6 | 44 | Citations (PDF) |
| 237 | Extraluminal factors contributing to inflammatory bowel disease | 4.8 | 7 | Citations (PDF) |
| 238 | Was ist gesichert in der Therapie chronisch entzündlicher Darmerkrankungen? | 0.4 | 0 | Citations (PDF) |
| 239 | Combined Pulse Electroporation – A Novel Strategy for Highly Efficient Transfection of Human and Mouse Cells | 2.4 | 59 | Citations (PDF) |
| 240 | An internet portal for the development of clinical practice guidelines | 1.7 | 6 | Citations (PDF) |
| 241 | Leptin: A Critical Regulator of CD4+ T-cell Polarization in Vitro and in Vivo | 2.6 | 112 | Citations (PDF) |
| 242 | Cytomegalovirus-esophagitis as initial presentation of HIV infection mimicking adenocarcinoma | 2.3 | 0 | Citations (PDF) |
| 243 | Clostridium difficile infection of the small bowel—two case reports with a literature survey | 1.9 | 21 | Citations (PDF) |
| 244 | Chronisch entzündliche Darmerkrankungen und Schwangerschaft | 0.3 | 6 | Citations (PDF) |
| 245 | Adipokine signaling in inflammatory bowel disease | 3.0 | 41 | Citations (PDF) |
| 246 | Clinical aspects of inflammatory bowel disease | 3.2 | 8 | Citations (PDF) |
| 247 | Leitlinie „Diagnostik und Therapie des Morbus Crohn“ – Kurzfassung für Internisten und Hausärzte | 0.1 | 2 | Citations (PDF) |
| 248 | Complement and Neutrophil Function Changes After Liver Resection in Humans | 2.8 | 9 | Citations (PDF) |
| 249 | HDAC inhibitors in models of inflammation-related tumorigenesis | 8.8 | 73 | Citations (PDF) |
| 250 | Impaired counter-regulation of interleukin-1 by the soluble IL-1 receptor type II in patients with chronic liver disease | 1.8 | 20 | Citations (PDF) |
| 251 | Interleukin-18, together with interleukin-12, induces severe acute pancreatitis in obese but not in nonobese leptin-deficient mice | 7.6 | 71 | Citations (PDF) |
| 252 | Nucleotide Oligomerization Domains 1 and 2: Regulation of Expression and Function in Preadipocytes | 0.6 | 47 | Citations (PDF) |
| 253 | Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice | 21.2 | 108 | Citations (PDF) |
| 254 | Resistance of Janus Kinase-2 Dependent Leptin Signaling in Natural Killer (NK) Cells: A Novel Mechanism of NK Cell Dysfunction in Diet-Induced Obesity | 2.6 | 89 | Citations (PDF) |
| 255 | S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn” | 0.3 | 148 | Citations (PDF) |
| 256 | Noduläre regenerative
Hyperplasie als Nebenwirkung von Azathioprin bei Morbus Crohn | 0.2 | 8 | Citations (PDF) |
| 257 | Kurzfassung der aktualisierten
S3-Leitlinie der DGVS und des Kompetenznetzwerkes CED zur Diagnostik und
Behandlung des Morbus Crohn | 0.2 | 6 | Citations (PDF) |
| 258 | Esophageal giant ulcer in primary human immunodeficiency virus infection is associated with an infiltration of activated T cells | 1.8 | 13 | Citations (PDF) |
| 259 | Leptin-Dependent Toll-Like Receptor Expression and Responsiveness in Preadipocytes and Adipocytes | 3.4 | 92 | Citations (PDF) |
| 260 | Shift Towards Pro-inflammatory Intestinal Bacteria Aggravates Acute Murine Colitis via Toll-like Receptors 2 and 4 | 2.4 | 203 | Citations (PDF) |
| 261 | Histone Hyperacetylation Is Associated with Amelioration of Experimental Colitis in Mice | 0.6 | 307 | Citations (PDF) |
| 262 | Immunbiologie chronisch-entzündlicher Darmerkrankungen | 0.2 | 0 | Citations (PDF) |
| 263 | The Histone Deacetylase Inhibitor ITF2357 Reduces Production of Pro-Inflammatory Cytokines In Vitro and Systemic Inflammation In Vivo | 5.8 | 328 | Citations (PDF) |
| 264 | Defining the role of T cell-derived leptin in the modulation of hepatic or intestinal inflammation in mice | 3.5 | 40 | Citations (PDF) |
| 265 | Colitis ulcerosa – Standard-therapie 2004 | 0.2 | 1 | Citations (PDF) |
| 266 | Die Stellung von Leptin im Immunsystem - Verbindung von Endokrinologie und Immunologie | 0.2 | 1 | Citations (PDF) |
| 267 | Suppressor αβ T Lymphocytes Control Innate Resistance to Endotoxic Shock | 3.8 | 6 | Citations (PDF) |
| 268 | Inhibition of Early Airway Neutrophilia Does Not Affect Development of Airway Hyperresponsiveness | 4.3 | 41 | Citations (PDF) |
| 269 | Development of intestinal inflammation in double IL-10- and leptin-deficient mice | 3.0 | 40 | Citations (PDF) |
| 270 | Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease | 3.5 | 130 | Citations (PDF) |
| 271 | The Interleukin-1β-Converting Enzyme Inhibitor Pralnacasan Reduces Dextran Sulfate Sodium-Induced Murine Colitis and T Helper 1 T-Cell Activation | 3.3 | 112 | Citations (PDF) |
| 272 | ROLE OF LEPTIN IN ACUTE PANCREATITIS INDUCED BY IL-12 AND IL-18 | 2.4 | 0 | Citations (PDF) |
| 273 | Standards of medical treatment and nutrition in Crohn’s disease | 1.7 | 1 | Citations (PDF) |
| 274 | The Specific Type-4 Phosphodiesterase Inhibitor Mesopram Alleviates Experimental Colitis in Mice | 3.3 | 39 | Citations (PDF) |
| 275 | Generation and characterization of mice transgenic for human IL-18-binding protein isoforma | 3.0 | 50 | Citations (PDF) |
| 276 | The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines | 7.6 | 499 | Citations (PDF) |
| 277 | Pulmonary Inflammation Induced by Pseudomonas aeruginosa Lipopolysaccharide, Phospholipase C, and Exotoxin A: Role of Interferon Regulatory Factor 1 | 2.7 | 75 | Citations (PDF) |
| 278 | Leptin: A pivotal mediator of intestinal inflammation in mice | 1.0 | 244 | Citations (PDF) |
| 279 | Leptin deficiency, not obesity, protects mice from Con A-induced hepatitis | 3.2 | 88 | Citations (PDF) |
| 280 | Interferon-α
induces interleukin-18 binding protein in chronic hepatitis C patients | 3.5 | 48 | Citations (PDF) |
| 281 | Neutrophil-independent mechanisms of caspase-1– and IL-18–mediated ischemic acute tubular necrosis in mice | 10.7 | 300 | Citations (PDF) |
| 282 | Neutrophil-independent mechanisms of caspase-1– and IL-18–mediated ischemic acute tubular necrosis in mice | 10.7 | 190 | Citations (PDF) |
| 283 | Neutrophil-independent mechanisms of caspase-1– and IL-18–mediated ischemic acute tubular necrosis in mice | 10.7 | 57 | Citations (PDF) |
| 284 | Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-γ and TNF-α production | 2.4 | 272 | Citations (PDF) |
| 285 | Phosphodiesterase type 4 inhibitor suppresses expression of anti-apoptotic members of the Bcl-2 family in B-CLL cells and induces caspase-dependent apoptosis | 10.4 | 24 | Citations (PDF) |
| 286 | IL-1β-converting enzyme (caspase-1) in intestinal inflammation | 7.6 | 420 | Citations (PDF) |
| 287 | Neutralization of IL-18 exerts anti-inflammatory activity in experimental colitis in mice | 1.0 | 1 | Citations (PDF) |
| 288 | Impaired IL-18 processing protects caspase-1–deficient mice from ischemic acute renal failure | 10.7 | 433 | Citations (PDF) |
| 289 | In vivo efficacy of the specific type 4 phosphodiesterase inhibitor mesopram in DSS-induced murine colitis | 1.0 | 0 | Citations (PDF) |
| 290 | Leptin-deficient (Ob/Ob) mice are resistant to experimental colitis: Role of pro-inflammatory cytokines | 1.0 | 0 | Citations (PDF) |
| 291 | Multiple Muskelabszesse bei tibetanischer Patientin | 0.4 | 0 | Citations (PDF) |
| 292 | Extracellular ATP and TNF-α Synergize in the Activation and Maturation of Human Dendritic Cells | 0.6 | 180 | Citations (PDF) |
| 293 | Adenosine kinase inhibitor GP515 improves experimental colitis in mice by inhibition of TH1 cytokine synthesis | 1.0 | 6 | Citations (PDF) |
| 294 | Adrenaline enhances LPS-induced IL-10 synthesis: evidence for protein kinase A-mediated pathway | 1.3 | 42 | Citations (PDF) |
| 295 | Anti-inflammatory activities of cAMP-elevating agents: enhancement of IL-10 synthesis and concurrent suppression of TNF production | 3.0 | 174 | Citations (PDF) |
| 296 | Suppression of tumor necrosis factor-α production by interleukin-10 is enhanced by cAMP-elevating agents | 4.4 | 33 | Citations (PDF) |
| 297 | T-cell repertoires in refractory coeliac diseaseGut, 0, , gutjnl-2016-311816 | 21.2 | 21 | Citations (PDF) |
